id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2012-E-1241-0009,FDA,FDA-2012-E-1241,Letter from FDA CDER to the U.S. Patent and Trademark Office,Other,Letter(s),2015-03-11T04:00:00Z,2015,3,2015-03-11T04:00:00Z,,2015-03-11T13:16:01Z,,0,0,0900006481a3aeed
FDA-2012-E-1241-0008,FDA,FDA-2012-E-1241,"Determination of Regulatory Review Period for Purposes of Patent
Extension; Xience Prime Ll Everolimus Eluting Coronary Stent System",Notice,General Notice,2014-06-10T04:00:00Z,2014,6,2014-06-10T04:00:00Z,2014-08-12T03:59:59Z,2014-06-10T14:15:01Z,2014-13445,0,0,0900006481735139
FDA-2012-E-1241-0007,FDA,FDA-2012-E-1241,Letter from FDA CDER to the U.S. Patent and Trademark Office,Other,Letter(s),2014-05-12T04:00:00Z,2014,5,2014-05-12T04:00:00Z,,2014-05-12T16:48:30Z,,0,0,09000064816f185a
FDA-2012-E-1241-0006,FDA,FDA-2012-E-1241,"Letter from U.S. Patent and Trademark Office to Baker Botts, LLP",Other,Letter(s),2014-04-01T04:00:00Z,2014,4,2014-04-01T04:00:00Z,,2014-04-01T15:57:17Z,,0,0,0900006481695017
FDA-2012-E-1241-0005,FDA,FDA-2012-E-1241,Letter from U.S. Patent and Trademark Office  to FDA CDER,Other,Letter(s),2014-03-28T04:00:00Z,2014,3,2014-03-28T04:00:00Z,,2014-03-28T20:24:21Z,,0,0,090000648168d0ce
FDA-2012-E-1241-0004,FDA,FDA-2012-E-1241,FDA/CDER  to U.S. Patent and Trademark Office - Letter,Other,Letter(s),2013-03-04T05:00:00Z,2013,3,2013-03-04T05:00:00Z,,2013-03-04T16:42:40Z,,0,0,0900006481216ba5
FDA-2012-E-1241-0003,FDA,FDA-2012-E-1241,"Abbott Cardiovascular Systems Inc. (Baker Botts, LLP) - Supplement",Other,Supplement (SUP),2012-12-28T05:00:00Z,2012,12,2012-12-28T05:00:00Z,,2012-12-28T17:24:52Z,,0,0,090000648119e0e9
FDA-2012-E-1241-0001,FDA,FDA-2012-E-1241,"Abbott Cardiovascular Systems Inc. (Baker Botts, LLP) - Patent Extension Application",Other,Application,2012-12-28T05:00:00Z,2012,12,2012-12-28T05:00:00Z,,2012-12-28T17:24:50Z,,0,0,090000648119e0e4
FDA-2012-E-1241-0002,FDA,FDA-2012-E-1241,U.S. Patent and Trademark Office - Letter,Other,Letter(s),2012-12-28T05:00:00Z,2012,12,2012-12-28T05:00:00Z,,2012-12-28T17:24:51Z,,0,0,090000648119e0e6